GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Other Current Receivables

RGC (Regencell Bioscience Holdings) Other Current Receivables : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Other Current Receivables?

Regencell Bioscience Holdings's Other Current Receivables for the quarter that ended in Dec. 2024 was $0.00 Mil.

Regencell Bioscience Holdings's annual Other Current Receivables increased from Jun. 2022 ($0.03 Mil) to Jun. 2023 ($0.06 Mil) and increased from Jun. 2023 ($0.06 Mil) to Jun. 2024 ($0.15 Mil).


Regencell Bioscience Holdings Other Current Receivables Historical Data

The historical data trend for Regencell Bioscience Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Other Current Receivables Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Receivables
Get a 7-Day Free Trial - 0.01 0.03 0.06 0.15

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 - 0.15 -

Regencell Bioscience Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Regencell Bioscience Holdings Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.